Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's Disease.
- DOI
- 10.3390/jcm13061539
- Published
- 2024 Mar 7
- Container
- Journal of clinical medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/jcm13061539,
title = {Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's Disease.},
author = {Bertin L and Barberio B and Gubbiotti A and Bertani L and Costa F and Ceccarelli L and Visaggi P and Bodini G and Pasta A and Sablich R and Urbano MT and Ferronato A and Buda A and De Bona M and Del Corso G and Massano A and Angriman I and Scarpa M and Zingone F and Savarino EV},
year = {2024},
journal = {Journal of clinical medicine},
doi = {10.3390/jcm13061539},
url = {https://doi.org/10.3390/jcm13061539}
}RIS
TY - JOUR TI - Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's Disease. AU - Bertin L AU - Barberio B AU - Gubbiotti A AU - Bertani L AU - Costa F AU - Ceccarelli L AU - Visaggi P AU - Bodini G AU - Pasta A AU - Sablich R AU - Urbano MT AU - Ferronato A AU - Buda A AU - De Bona M AU - Del Corso G AU - Massano A AU - Angriman I AU - Scarpa M AU - Zingone F AU - Savarino EV PY - 2024 JO - Journal of clinical medicine DO - 10.3390/jcm13061539 UR - https://doi.org/10.3390/jcm13061539 ER -
APA
L, B., B, B., A, G., L, B., F, C., L, C., P, V., G, B., A, P., R, S., MT, U., A, F., A, B., M, D. B., G, D. C., A, M., I, A., M, S., F, Z., & EV, S. (2024). Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's Disease.. Journal of clinical medicine. https://doi.org/10.3390/jcm13061539
Source records
- pubmed · retrieved 2026-09-26T10:52:11.503Z